Cargando…
Polyphenol-Rich Extracts of Xylopia and Aframomum Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation in Diet-Induced Obese Mice
[Image: see text] Metabolic syndrome is a complex condition associated with a series of pathologies featuring glucose intolerance, diabetes, high blood pressure, dyslipidemia, microalbuminuria, overweight, and obesity. It is also related to nonalcoholic fatty liver disease (NAFLD), recognized as the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016817/ https://www.ncbi.nlm.nih.gov/pubmed/35449947 http://dx.doi.org/10.1021/acsomega.2c00050 |
_version_ | 1784688610831761408 |
---|---|
author | Nwakiban Atchan, Achille Parfait Shivashankara, Shilpa Talkad Piazza, Stefano Tchamgoue, Armelle Deutou Beretta, Giangiacomo Dell’Agli, Mario Magni, Paolo Agbor, Gabriel Agbor Kuiaté, Jules-Roger Manjappara, Uma Venkateswaran |
author_facet | Nwakiban Atchan, Achille Parfait Shivashankara, Shilpa Talkad Piazza, Stefano Tchamgoue, Armelle Deutou Beretta, Giangiacomo Dell’Agli, Mario Magni, Paolo Agbor, Gabriel Agbor Kuiaté, Jules-Roger Manjappara, Uma Venkateswaran |
author_sort | Nwakiban Atchan, Achille Parfait |
collection | PubMed |
description | [Image: see text] Metabolic syndrome is a complex condition associated with a series of pathologies featuring glucose intolerance, diabetes, high blood pressure, dyslipidemia, microalbuminuria, overweight, and obesity. It is also related to nonalcoholic fatty liver disease (NAFLD), recognized as the most familiar cause of chronic liver disease worldwide. The overall prevalence of metabolic syndrome and, consequently, the one of NAFLD is constantly increasing worldwide. The initial management of these diseases involves lifestyle modifications, including changes in diet and physical exercise. In addition to conventional drugs like orlistat, botanicals are traditionally used to counteract these disorders, and some of them are currently under evaluation. The present work evaluated the in vivo beneficial effects of hydroalcoholic extracts of two Cameroonian spices, focusing on obesity-related hepatic lipid injury in high-fat-fed C57BL/6 mice. Hydroethanolic extracts were prepared and characterized by reverse phase-high-performance liquid chromatography (HPLC)-photodiode array detection and ultra performance liquid chromatography-triple time-of-flight electrospray ionization tandem mass spectroscopy (TOF-ESI-MS/MS) analysis. Plant extracts were orally administered for 30 days at different dose levels (100 and 200 mg kg(–1) body weight (BW)) to obese C57BL/6 mice. Food intake (FI) and BW were recorded daily. Plasma biochemical parameters and lipid content were estimated at the beginning and at the end of the experiment. Liver tissues were subjected to histological examinations, lipid content, as well as oxidative stress markers, and FAME (fatty acid methyl esters) were estimated. Oral administration of extracts at 200 mg kg(–1) BW significantly reduced FI and prevented BW gain. A decrease in the weight of the liver and a decrease in the hepatic and plasma lipid content were observed. Plasma enzyme (serum glutamic-oxaloacetic transaminase, SGOT; serum glutamic pyruvic transaminase, SGPT; alkaline phosphatase, ALP) activities were not indicative of any organ damage. Chemical analysis suggested that phenolic acids (4-caffeoylquinic acid, p-coumaric acid 4-O-glucoside, 5-caffeoylshikimic acid, caffeic acid hexose, and 4-O-methyl gallic acid) and flavonoids (morusin derivatives, naringenin-7-O-glucoside, and homoisoflavanone) identified in the extracts could potentially justify the biological properties observed. The main findings of this study showed that Xylopia parviflora(A. Rich.) Benth and Aframomum citratum(Pereira ex Oliv. et Hanb.) K. Shum decreased hepatic lipid accumulation in high-fat-diet (HFD)-induced obese C57BL/6 mice and confirmed, at least in part, our previous in vitro and ex vivo studies. The molecular mechanisms underlying these effects are still unclear and will be explored in the future. |
format | Online Article Text |
id | pubmed-9016817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-90168172022-04-20 Polyphenol-Rich Extracts of Xylopia and Aframomum Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation in Diet-Induced Obese Mice Nwakiban Atchan, Achille Parfait Shivashankara, Shilpa Talkad Piazza, Stefano Tchamgoue, Armelle Deutou Beretta, Giangiacomo Dell’Agli, Mario Magni, Paolo Agbor, Gabriel Agbor Kuiaté, Jules-Roger Manjappara, Uma Venkateswaran ACS Omega [Image: see text] Metabolic syndrome is a complex condition associated with a series of pathologies featuring glucose intolerance, diabetes, high blood pressure, dyslipidemia, microalbuminuria, overweight, and obesity. It is also related to nonalcoholic fatty liver disease (NAFLD), recognized as the most familiar cause of chronic liver disease worldwide. The overall prevalence of metabolic syndrome and, consequently, the one of NAFLD is constantly increasing worldwide. The initial management of these diseases involves lifestyle modifications, including changes in diet and physical exercise. In addition to conventional drugs like orlistat, botanicals are traditionally used to counteract these disorders, and some of them are currently under evaluation. The present work evaluated the in vivo beneficial effects of hydroalcoholic extracts of two Cameroonian spices, focusing on obesity-related hepatic lipid injury in high-fat-fed C57BL/6 mice. Hydroethanolic extracts were prepared and characterized by reverse phase-high-performance liquid chromatography (HPLC)-photodiode array detection and ultra performance liquid chromatography-triple time-of-flight electrospray ionization tandem mass spectroscopy (TOF-ESI-MS/MS) analysis. Plant extracts were orally administered for 30 days at different dose levels (100 and 200 mg kg(–1) body weight (BW)) to obese C57BL/6 mice. Food intake (FI) and BW were recorded daily. Plasma biochemical parameters and lipid content were estimated at the beginning and at the end of the experiment. Liver tissues were subjected to histological examinations, lipid content, as well as oxidative stress markers, and FAME (fatty acid methyl esters) were estimated. Oral administration of extracts at 200 mg kg(–1) BW significantly reduced FI and prevented BW gain. A decrease in the weight of the liver and a decrease in the hepatic and plasma lipid content were observed. Plasma enzyme (serum glutamic-oxaloacetic transaminase, SGOT; serum glutamic pyruvic transaminase, SGPT; alkaline phosphatase, ALP) activities were not indicative of any organ damage. Chemical analysis suggested that phenolic acids (4-caffeoylquinic acid, p-coumaric acid 4-O-glucoside, 5-caffeoylshikimic acid, caffeic acid hexose, and 4-O-methyl gallic acid) and flavonoids (morusin derivatives, naringenin-7-O-glucoside, and homoisoflavanone) identified in the extracts could potentially justify the biological properties observed. The main findings of this study showed that Xylopia parviflora(A. Rich.) Benth and Aframomum citratum(Pereira ex Oliv. et Hanb.) K. Shum decreased hepatic lipid accumulation in high-fat-diet (HFD)-induced obese C57BL/6 mice and confirmed, at least in part, our previous in vitro and ex vivo studies. The molecular mechanisms underlying these effects are still unclear and will be explored in the future. American Chemical Society 2022-03-30 /pmc/articles/PMC9016817/ /pubmed/35449947 http://dx.doi.org/10.1021/acsomega.2c00050 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Nwakiban Atchan, Achille Parfait Shivashankara, Shilpa Talkad Piazza, Stefano Tchamgoue, Armelle Deutou Beretta, Giangiacomo Dell’Agli, Mario Magni, Paolo Agbor, Gabriel Agbor Kuiaté, Jules-Roger Manjappara, Uma Venkateswaran Polyphenol-Rich Extracts of Xylopia and Aframomum Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation in Diet-Induced Obese Mice |
title | Polyphenol-Rich Extracts of Xylopia and Aframomum
Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation
in Diet-Induced Obese Mice |
title_full | Polyphenol-Rich Extracts of Xylopia and Aframomum
Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation
in Diet-Induced Obese Mice |
title_fullStr | Polyphenol-Rich Extracts of Xylopia and Aframomum
Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation
in Diet-Induced Obese Mice |
title_full_unstemmed | Polyphenol-Rich Extracts of Xylopia and Aframomum
Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation
in Diet-Induced Obese Mice |
title_short | Polyphenol-Rich Extracts of Xylopia and Aframomum
Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation
in Diet-Induced Obese Mice |
title_sort | polyphenol-rich extracts of xylopia and aframomum
species show metabolic benefits by lowering hepatic lipid accumulation
in diet-induced obese mice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016817/ https://www.ncbi.nlm.nih.gov/pubmed/35449947 http://dx.doi.org/10.1021/acsomega.2c00050 |
work_keys_str_mv | AT nwakibanatchanachilleparfait polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT shivashankarashilpatalkad polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT piazzastefano polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT tchamgouearmelledeutou polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT berettagiangiacomo polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT dellaglimario polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT magnipaolo polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT agborgabrielagbor polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT kuiatejulesroger polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice AT manjapparaumavenkateswaran polyphenolrichextractsofxylopiaandaframomumspeciesshowmetabolicbenefitsbyloweringhepaticlipidaccumulationindietinducedobesemice |